Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 97,308 | 167,679 | 117,558 | 115,401 | 43,375 |
| Depreciation Amortization | 117,531 | 130,542 | 100,562 | 93,307 | 101,151 |
| Income taxes - deferred | -26,471 | -5,219 | -11,039 | 4,783 | 5,013 |
| Accounts receivable | -14,881 | 6,956 | -24,193 | -24,421 | -34,974 |
| Other Working Capital | -23,653 | -101,962 | -74,701 | 25,503 | -15,177 |
| Other Operating Activity | 143,387 | -16,271 | 73,564 | 58,485 | 72,875 |
| Operating Cash Flow | $293,221 | $181,725 | $181,751 | $273,058 | $172,263 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,405 | -16,025 | -36,315 | -189,719 | -94,487 |
| Net Acquisitions | -60,180 | -107,615 | -242,352 | -2,000 | 8,142 |
| Other Investing Activity | -87,962 | -38,255 | -43,722 | 47,931 | 0 |
| Investing Cash Flow | $-179,547 | $-161,895 | $-322,389 | $-143,788 | $-86,345 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 300,000 | 950,000 | 110,000 | 330,000 | 0 |
| Debt Repayment | -306,250 | -502,688 | -72,250 | -339,625 | -17,500 |
| Common Stock Issued | 7,893 | -79,867 | 7,214 | 7,016 | 6,547 |
| Common Stock Repurchased | -175,000 | -225,000 | N/A | -75,000 | N/A |
| Other Financing Activity | -5,103 | -33,627 | -6,807 | -22,755 | -4,796 |
| Financing Cash Flow | $-178,460 | $108,818 | $38,157 | $-100,364 | $-15,749 |
| Exchange Rate Effect | 3,463 | -685 | -3,185 | -3,936 | -2,978 |
| Beginning Cash Position | 306,763 | 178,800 | 284,466 | 259,496 | 192,305 |
| End Cash Position | 245,440 | 306,763 | 178,800 | 284,466 | 259,496 |
| Net Cash Flow | $-61,323 | $127,963 | $-105,666 | $24,970 | $67,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | 293,221 | 181,725 | 181,751 | 273,058 | 172,263 |
| Capital Expenditure | -32,780 | -39,278 | -38,125 | -191,327 | -96,509 |
| Free Cash Flow | 260,441 | 142,447 | 143,626 | 81,731 | 75,754 |